TY  - CHAP
M1  - Book, Section
TI  - Glossary
A1  - Cullen, Laura
A1  - Hanrahan, Kirsten
A1  - Farrington, Michele
A1  - Tucker, Sharon
A1  - Edmonds, Stephanie
PY  - 2023
T2  - Evidence-Based Practice in Action: Comprehensive Strategies, Tools, and Tips From University of Iowa Hospitals & Clinics, 2e
AB  - Adaptation:  Modification  of  an  EBP  change  to  improve  the  fit  with  the  local  setting.Adoption:  Active  decision  by  an  individual,  organization,  or  community  to  change  behaviors  and  use  an  EBP  because  of  the  benefit  or  relative  advantage  offered.AGREE  II  (Appraisal  of  Guidelines  for  Research  &  Evaluation  II):  Established  tool  that  provides  a  framework  for  assessing  the  quality  and  reporting  of  clinical  practice  guidelines  (CPGs).Anecdotal  evidence:  Informal  reports  supported  by  local  experts,  local  data,  theory,  or  scientific  principles.Balancing  measures:  Indicators  that  monitor  for  systemic  effects,  risks,  and  unintended  consequences  from  the  EBP  change.Body  of  evidence:  Relevant  research,  synthesis  reports,  patient  preferences,  case  reports,  local  data,  and  expert  opinion  that  answers  clinical  questions  and  guides  development  of  practice  recommendations.Bottom-up:  Clinical  problems  and  solutions  driven  by  frontline  clinicians  and  elevated  to  leaders.Capacity:  Ability  or  power  to  do  or  produce,  as  in  building  ability,  skills,  and  resources  to  achieve  more.Case-control  study:  Retrospective  design  where  subjects  with  a  certain  outcome  or  disease  (cases)  are  grouped  and  then  exposures  (risks)  are  compared  to  matched  controls.Case  report:  Retrospective  account  of  an  individual  or  select  individuals  with  unusual  or  pertinent  diseases,  interventions,  or  therapies.Change  agent:  Influential  person  who,  based  on  their  role,  expertise,  or  leadership  style,  can  impact  adoption  of  an  EBP  change.Climate:  How  the  work  environment  is  experienced.Clinical  practice  guidelines  (CPGs):  Document  including  recommendations  for  or  against  related  assessments,  procedures,  tests,  or  interventions;  based  on  a  systematic  review  of  evidence  and  analysis  of  benefits  versus  harms  intending  to  change  clinician  practices  and  to  optimize  patient  care.Clinical  practice  recommendation:  Statements  informed  by  evidence  that  include  authoritative  suggestions  intended  to  optimize  patient  care.Clinical  significance:  Effect  of  the  EBP  change  in  a  real-world  setting  showing  a  meaningful  difference  in  outcomes.Co-design:  Method  to  engage  patients  as  equal  partners  in  planning  the  EBP  change.Cohort  study:  Design  in  which  prospective  subjects  are  grouped  by  exposure  (cohort)  and  followed  over  time  to  determine  outcomes.Consensus  statement:  Report  of  a  panel  of  experts  based  on  their  evaluation  of  the  state  of  scientific  knowledge  available  at  the  time,  with  a  determination  for  practice.Consistency  of  evidence:  Degree  to  which  studies  report  similar  results  or  have  similar  implications  for  practice.Context:  Setting  within  which  an  EBP  change  is  designed  to  be  used;  includes  the  social,  regulatory,  norms,  and  cultures  of  the  setting.Continuous  data:  Information  that  is  measured  and  can  take  any  value  and  can  be  divided  in  half  (e.g.,  lab  values,  weight).Core  components:  Key  behaviors  or  active  ingredients  identified  from  the  best  evidence  for  use  in  the  EBP  change  that  are  essential  for  achieving  outcomes.Cross-sectional  study:  Prospective  observational  design  that  examines  health  status,  behavior,  and  other  risk  factors  of  a  subpopulation  measured  at  a  given  time.Decision  support:  Filtered  and  timely  information  to  reduce  delays,  increase  accuracy,  reduce  risks,  and  standardize  practices.De-implementation:  Stopping  or  removing  practices  that  are  not  evidence-based,  do  not  improve  care,  are  ineffective,  and  may  be  harmful.Diffusion:  Passive  spread  of  an  intervention  or  practice  change.Discrete  data:  Information  that  is  measured  and  can  only  take  certain  values  and  cannot  be  divided  in  half  (e.g.,  number  of  patients,  falls).Dissemination:  Active  approach  to  communicating  ...
SN  - 
PB  - Sigma Theta Tau International
CY  - New York, NY
Y2  - 2025/07/17
UR  - apn.mhmedical.com/content.aspx?aid=1193307360
ER  -